Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Correction: Alpelisib and fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the French early access program.
Oncogene. 2023 Apr;42(17):1417. doi: 10.1038/s41388-023-02615-8.
Oncogene. 2023.
PMID: 36922682
No abstract available.
Alpelisib and fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the French early access program.
Bello Roufai D, Gonçalves A, De La Motte Rouge T, Akla S, Blonz C, Grenier J, Gligorov J, Saghatchian M, Bailleux C, Simon H, Desmoulins I, Tharin Z, Renaud E, Bertho M, Benderra MA, Delaloge S, Robert L, Cottu P, Pierga JY, Loirat D, Bertucci A, Renouf B, Bidard FC, Lerebours F.
Bello Roufai D, et al. Among authors: blonz c.
Oncogene. 2023 Jun;42(23):1951-1956. doi: 10.1038/s41388-022-02585-3. Epub 2023 Jan 7.
Oncogene. 2023.
PMID: 36611120
Item in Clipboard
Everolimus or sunitinib as first-line treatment of metastatic papillary renal cell carcinoma: A retrospective study of the GETUG group (Groupe d'Etude des Tumeurs Uro-Génitales).
Cancel M, Fromont G, Blonz C, Chevreau C, Rioux-Leclercq N, Laguerre B, Oudard S, Gross-Goupil M, Gravis G, Goldwasser F, Rolland F, Delva R, Moise L, Emambux S, Vassal C, Zanetta S, Penel N, Fléchon A, Barthélémy P, Saldana C, Lefort F, Escudier B, Linassier C, Albiges L.
Cancel M, et al. Among authors: blonz c.
Eur J Cancer. 2021 Oct 4;158:1-11. doi: 10.1016/j.ejca.2021.08.046. Online ahead of print.
Eur J Cancer. 2021.
PMID: 34619467
Item in Clipboard
A pharmacokinetic evaluation of alpelisib for the treatment of HR+, HER2-negative, PIK3CA-mutated advanced or metastatic breast cancer.
Bertho M, Patsouris A, Augereau P, Robert M, Frenel JS, Blonz C, Campone M.
Bertho M, et al. Among authors: blonz c.
Expert Opin Drug Metab Toxicol. 2021 Feb;17(2):139-152. doi: 10.1080/17425255.2021.1844662. Epub 2020 Dec 8.
Expert Opin Drug Metab Toxicol. 2021.
PMID: 33213227
Review.
Item in Clipboard
Targeting the PI3K/Akt/mTOR pathway in estrogen-receptor positive HER2 negative advanced breast cancer.
du Rusquec P, Blonz C, Frenel JS, Campone M.
du Rusquec P, et al. Among authors: blonz c.
Ther Adv Med Oncol. 2020 Jul 28;12:1758835920940939. doi: 10.1177/1758835920940939. eCollection 2020.
Ther Adv Med Oncol. 2020.
PMID: 32782489
Free PMC article.
Review.
Item in Clipboard
Cite
Cite